Author

Jules L. Griffin

University of Aberdeen

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell signaling & trafficking· 1 Research Focus:development & morphogenesis· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Research Focus:metabolism & bioenergetics· 1 Organism:mouse· 1 Organism:zebrafish· 1

Frequent Co-Authors

Calum A. MacRaeiD· 1 shared Cecilia CastroiD· 1 shared Emanuela RicciottiiD· 1 shared Garret A. FitzGeraldiD· 1 shared Manu BeerensiD· 1 shared Nicholas F. LahensiD· 1 shared Philip G. HainesiD· 1 shared Soon Yew TangiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Calum A. MacRaeORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cyclooxygenase-2 disruption predisposes to heart failure with preserved ejection fraction

Emanuela Ricciotti, Philip G. Haines, Manu Beerens, Uri Kartoun, Cecilia Castro, Soon Yew Tang, Soumita Ghosh, Ujjalkumar Subhash Das, Nicholas F. Lahens, Tao Wang, Jules L. Griffin, Stanley Y. Shaw, Calum A. MacRae, Garret A. FitzGerald

This study shows that COX-2 deletion or inhibition leads to heart failure with preserved ejection fraction in zebrafish, mice, and humans.

bioRxiv · Sep 28, 2024 · PreprintPharmacology & Toxicology